Note: Ingredients listed on restricted chemical lists
General Information
Revision date
2016-03-08
Product name
Eloxi Suspension
1.2.1 Relevant identified uses
Non-steroidal anti-inflammatory drug for use in dogs only. Eloxi Suspension is indicated for the control of pain and inflammation associated with osteoarthritis in dogs
supplier name
Henry Schein Animal Health
Manufacturer Name
Henry Schein Animal Health
Emergency telephone
001 717 944 3081
Icons in SDS
Company Information
company name
Norbrook Laboratories Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
enquiries@norbrook.co.uk
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360
Hazard statements
Code
Statements
H360
May damage fertility or the unborn child
Section 2
Classification (GHS-US)
Repr. 1B H360
Hazard statements
see section 16 : H360 - May damage fertility or the unborn child.
2.2 Label elements
GHS-US Labeling
Hazard pictograms
GHS08
Signal word
Danger
Precautionary statements
P201 - Obtain special instructions before use. P202 - Do not handle until all safety precautions have been read and understood. P280 - Wear protective gloves, protective clothing, and eye protection. P308+P313 - If exposed or concerned: Get medical advice/attention. P405 - Store locked up. P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations.
2.3 Other hazards
Exposure may aggravate those with pre-existing eye, skin, or respiratory conditions. 2.4.
Ingredient(s) with unknown acute toxicity
No data available
